Argument of Criticality Undercut Position that Non-Disclosed Art was Merely Cumulative
In Belcher Pharmaceuticals, LLC v. Hospira, Inc., [2020-1799] (September 1, 2021), the Federal Circuit affirmed the district court’s determination that Belcher’s Chief Science Officer engaged in inequitable conduct by withholding material information from the USPTO during prosecution of U.S. Patent … Continue reading Argument of Criticality Undercut Position that Non-Disclosed Art was Merely Cumulative
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed